Get the Stockscreener App
0.00
100.00%
-179.95
After Hours:
179.95
179.95
+
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Masimo Corp is a medical technology company. The company oepates in single segment namely Healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, and others.
See More
Previous Close:
$179.95
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$9.42B
Revenue:
$1.56B
Net Income/Loss:
$216.80M
P/E Ratio:
0.00
EPS:
1.458
Net Cash Flow:
$206.10M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$179.99
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
0.00 | 9.42B | 1.56B | 216.80M | 206.10M | 1.458 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-27-26 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-17-25 | Initiated | BofA Securities | Neutral |
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Judge Upholds $643M Masimo Verdict - Orange County Business Journal
Masimo Corp Agencies, 2023 - OpenSecrets
The Denon AVR-X3800H. Masimo leans on flexible 8K home cinema - AD HOC NEWS
Masimo Heads For $10B Buyout After Winning Blood Oxygen Patent Case Against Apple - Stocktwits
MSN Money - MSN
Full Fed. Circ. Won't Review Apple's ITC Loss Against Masimo - Law360
Apple loses its bid to get out of paying Masimo $634 million - MacTech.com
Apple loses bid to overturn $634 million Masimo patent verdict, new trial also denied - 9to5Mac
Denon AVR-X1800H by Masimo Corp.compact 8K receiver for Dolby Atmos living rooms - AD HOC NEWS
Masimo Retains $634 Million Patent Win Over Apple Watch Feature - Bloomberg Law News
Apple Can't Get Judge To Toss Masimo's $634M Patent Verdict - Law360
SIRI stock surges 5% after-hours on S&P MidCap 400 inclusion - MSN
Denon AVR-X2800H by Masimo Corp.mid-range receiver gets HEOS and 8K update - ad-hoc-news.de
Danaher-Masimo close caps med tech’s strongest first-half since 2022 - BioWorld News
Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover - Sahm
Masimo Corp highlights patient monitoring portfolio as Nasdaq-listed medical technology player - Ad Hoc News
The Denon AVR-X2800H. A mid-range receiver quietly pushing Masimo’s Sound United audio strategy - ad-hoc-news.de
Masimo Corp focuses on patient monitoring innovation as investors assess long-term growth prospects - ad-hoc-news.de
Danaher slips as investors weigh soft diagnostics trends and Masimo integration risk - Quiver Quantitative
Masimo Radius T from Masimo Corp.wireless wearable for hospital telemetry - ad-hoc-news.de
California Judge Denies Masimo Board Effort to Toss Kiani Case - Bloomberg Law News
Denon AH-D5200 from Masimo Corp.closed-back wood headphones quietly anchor the premium hi-fi line - ad-hoc-news.de
Denon AVR-X3800H from Masimo Corp.9.4-channel receiver pushes home theaters into 8K and HEOS stre - ad-hoc-news.de
Denon Home 350 from Masimo Corp.big-room wireless speaker with serious multiroom chops - ad-hoc-news.de
Danaher Corp adjusts guidance after Masimo deal. Analysts highlight cautious upside for the stock - Ad Hoc News
Deals tracker: Select Medical Holdings acquisition moves forward - Modern Healthcare
Lobbying Update: $50,000 of MASIMO CORPORATION lobbying was just disclosed - Quiver Quantitative
Danaher (DHR) Completes $9.9B Acquisition of Masimo Corporation - Yahoo Finance
Denon AVC-X3900H from Masimo Corp.9.4 channels and 8K-ready home cinema hub - Ad-hoc-news.de
The Denon AVR-X3800H from Masimo Corp.9.4-channel cinema, HDMI 2.1 and HEOS streaming - Ad-hoc-news.de
Danaher boosts product portfolio with the acquisition of Masimo - MSN
Danaher clears new AI milestone with Masimo, shares react on NYSE - Ad-hoc-news.de
Danaher clears FDA hurdle with Masimo, shares extend rebound on NYSE - Ad-hoc-news.de
Danaher Corp Stock (DHR) Moved Up by 4.91% on Jun 24: What Investors Need To Know - TradingKey
Danaher Is Down 22% This Year. Is the Masimo Acquisition the Entry Point Investors Have Been Waiting for? - The Motley Fool
Danaher achieves FDA clearance for Masimo feature, shares steady on NYSE - AD HOC NEWS
Masimo Receives FDA 510 Clearance for AI-Enabled Opioid-Induced Respiratory Depression Detection on Radius VSM® to Help Identify Respiratory Risk Sooner - Investing News Network
The Radius VSM from Masimo Corp.FDA-cleared opioid risk alerts on the wrist - AD HOC NEWS
California Forum Selection Clause Enforced in Lawsuit - The National Law Review
Danaher Finalizes $9.9B Purchase of Masimo - Orange County Business Journal
Masimo wins FDA clearance for wearable opioid-risk monitor - Stock Titan
Medtech business update: Spectrum Vascular acquires Piccolo Medical, Danaher acquires Masimo - Today's Medical Developments
ITC, Masimo Tell Full Fed. Circ. To Skip Apple Watch Review - Law360
Masimo Corp (MASI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Masimo Corp (MASI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Masimo Corp (MASI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Masimo Corp (MASI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Katie Szyman Steps Down from Masimo - Orange County Business Journal
Masimo CEO stepping down following acquisition by Danaher - Modern Healthcare
Silent monitoring boost, Masimo Stork smart baby monitor targets anxious new parents - AD HOC NEWS
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.04%
11.95%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):